| Literature DB >> 35291224 |
Jean Duchesne1, Olivier A Coubard2.
Abstract
Modelling how a pandemic is spreading over time is a challenging issue. The new coronavirus disease called COVID-19 does not escape this rule as it has embraced over two hundred countries. As for previous pandemics, several studies have attempted to model the occurrence of cases caused by COVID-19. However, no study has succeeded in accurately modelling the impact of the infectious agent. Here we show that COVID-19 daily case distribution in humans obeys a Gamma law, which two new parameters can describe without any adjustment. Though the Gamma law has been exploited for nearly two centuries to describe the statistical distribution of spatial or temporal quantities, the goodness-of-fit rationale using two or three parameters has remained enigmatic. The new Gamma law approach we demonstrate here emerges from actual data and sheds light on the underlying mechanisms of the observed phenomenon. This finding has promising applicability in the epidemiological domain and in all disciplines involving branching systems, for which our Gamma law approach may bring a solution to hitherto unsolved problems.Entities:
Keywords: COVID-19; Epidemiology; Gamma law; Humans; Statistical physics
Year: 2022 PMID: 35291224 PMCID: PMC8912979 DOI: 10.1016/j.idm.2022.02.004
Source DB: PubMed Journal: Infect Dis Model ISSN: 2468-0427
Fig. 1Schema of COVID-19 contamination tree. Points P/E represent the start/end, respectively, of the contagiousness duration of patient , patient and so on.
For the COVID-19 first-wave in 2020 and for each country (CH, China; GE, Germany; AU, Austria; IS, Israel; NZ, New Zealand; BE, Belgium; SP, Spain; IT, Italy; FR, France; FI, Finland; CZ, Czechia; SL, Slovenia; LI, Lithuania; CR, Croatia; LA, Latvia), we report the rate of cases per mille residents (Case/pop), numbers of days, total number of cases, mean (in days) and variance of the observed distribution of daily cases; (number) and (in days) values of the Gamma distribution; peak values (in frequency) of the observed and Gamma distributions; and P values of the Kolmogorov-Smirnov test between the observed distribution and, respectively, Gamma (P1) and Lognormal (P2) distributions.
| Country | Case/Pop | Days | Cases | Mean | Peakob | Peakga | P1 | P2 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CH | 0.05‰ | 54 | 77,251 | 21.6 | 56.2 | 17 | 1.3 | 0.060 | 0.056 | 0.735 | 0.572 |
| GE | 2.24‰ | 119 | 186,639 | 56.7 | 346.0 | 19 | 3.1 | 0.031 | 0.022 | 0.984 | 0.460 |
| AU | 1.76‰ | 72 | 15,701 | 35.0 | 125.4 | 20 | 1.8 | 0.048 | 0.037 | 0.874 | 0.607 |
| IS | 1.76‰ | 96 | 16,620 | 54.8 | 158.1 | 38 | 1.4 | 0.037 | 0.032 | 0.042 | 0.018 |
| NZ | 0.29‰ | 75 | 1497 | 32.5 | 84.7 | 25 | 1.3 | 0.050 | 0.045 | 0.497 | 0.275 |
| BE | 5.33‰ | 122 | 61,272 | 50.4 | 445.8 | 11 | 4.4 | 0.024 | 0.020 | 0.986 | 0.951 |
| SP | 4.94‰ | 85 | 234,188 | 42.9 | 184.3 | 20 | 2.1 | 0.037 | 0.031 | 0.710 | 0.347 |
| IT | 3.98‰ | 132 | 240,325 | 51.0 | 496.8 | 10 | 4.9 | 0.024 | 0.020 | 0.991 | 0.832 |
| FR | 2.00‰ | 100 | 135,114 | 54.8 | 254.3 | 24 | 2.3 | 0.031 | 0.026 | 0.683 | 0.266 |
| FI | 1.31‰ | 133 | 7256 | 56.9 | 543.1 | 12 | 4.8 | 0.023 | 0.018 | 0.992 | 0.215 |
| CZ | 0.76‰ | 72 | 8160 | 37.3 | 188.8 | 15 | 2.5 | 0.032 | 0.031 | 0.959 | 0.749 |
| SL | 0.70‰ | 81 | 1467 | 29.3 | 197.8 | 9 | 3.4 | 0.033 | 0.032 | 0.681 | 0.020 |
| LI | 0.58‰ | 81 | 1619 | 32.5 | 337.9 | 6 | 5.2 | 0.033 | 0.025 | 0.976 | 0.681 |
| CR | 0.56‰ | 77 | 2193 | 41.8 | 174.2 | 20 | 2.1 | 0.034 | 0.032 | 0.393 | 0.290 |
| LA | 0.56‰ | 89 | 1072 | 37.9 | 410.4 | 7 | 5.4 | 0.030 | 0.023 | 0.853 | 0.282 |
For the COVID-19 first-wave in 2020 and for each country (CH, China; GE, Germany; AU, Austria; IS, Israel; NZ, New Zealand; BE, Belgium; SP, Spain; IT, Italy; FR, France; FI, Finland; CZ, Czechia; SL, Slovenia; LI, Lithuania; CR, Croatia; LA, Latvia), we report the P values of the Kolmogorov-Smirnov test between the observed distribution and, respectively, Gamma (P1), Gaussian (P3) and Weibull (P4) distributions. The Lognormal distribution (P2) is not shown (see Table 1). Gray cells show the superiority of other than Gamma distributions.
Fig. 2Study 1. Histogram of probability density function (in frequency) of COVID-19 observed daily cases in (A) China (CH) and (B) Germany (GE), Austria (AU), Israel (IS), and New Zealand (NZ) using 7-day moving averages (solid line) and their theoretical fits by Gamma (solid-dotted line) and Lognormal (dotted line) distributions as a function of time (in days). P values are those of Kolmogorov-Smirnov tests between the observed distribution and each theoretical one. Tags indicate the corresponding dates of beginning, peaks of observed and Gamma distributions, and end in 2020.
Fig. 3Study 2. Histogram of probability density function (in frequency) of COVID-19 observed daily cases in Belgium (BE), Spain (SP), Italy (IT), France (FR), Finland (FI), Czechia (CZ), Slovenia (SL), Lithuania (LI), Croatia (CR), and Latvia (LA). Other notations as in Fig. 2.
Fig. 4Study 3. Histogram of probability density function (in frequency) of COVID-19 observed daily cases in Belgium (BE) and Italy (IT) using 7-day moving averages (solid line) and their theoretical fits by Gamma (solid-dotted line), Lognormal (dotted line), Gaussian (dashed line), and Weibull (dash-dotted line) distributions as a function of time (in days). Other notations as in Fig. 2.